Click here to get full coverage on Brain cancer drug developer hires veteran surgeon to lead studies - Stock Titan

Brain cancer drug developer hires veteran surgeon to lead studies  Stock Titan

Brain cancer drug developer hires veteran surgeon to lead studies - Stock Titan

Click here to get full coverage on Understanding Momentum Shifts in (CNSP) - Stock Traders Daily

Understanding Momentum Shifts in (CNSP)  Stock Traders Daily

Understanding Momentum Shifts in (CNSP) - Stock Traders Daily

Click here to get full coverage on CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer - The Globe and Mail

CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer  The Globe and Mail

CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer - The Globe and Mail

Click here to get full coverage on Tensions escalate between Niger and its former colonizer France - Peoples Dispatch

Tensions escalate between Niger and its former colonizer France  Peoples Dispatch

Tensions escalate between Niger and its former colonizer France - Peoples Dispatch

Click here to get full coverage on CNS Pharmaceuticals Appoints New Chief Medical Officer - TipRanks

CNS Pharmaceuticals Appoints New Chief Medical Officer  TipRanks

CNS Pharmaceuticals Appoints New Chief Medical Officer - TipRanks

Click here to get full coverage on News - FY25 Sea and Shore Sailors of the Year CNSP - DVIDS

News - FY25 Sea and Shore Sailors of the Year CNSP  DVIDS

News - FY25 Sea and Shore Sailors of the Year CNSP - DVIDS

Click here to get full coverage on CNSP - CNS Pharmaceuticals Latest Stock News & Market Updates - Stock Titan

CNSP - CNS Pharmaceuticals Latest Stock News & Market Updates  Stock Titan

CNSP - CNS Pharmaceuticals Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on CNS Pharmaceuticals (CNSP) CEO Outlines Strategic Vision for Fut - GuruFocus

CNS Pharmaceuticals (CNSP) CEO Outlines Strategic Vision for Fut  GuruFocus

CNS Pharmaceuticals (CNSP) CEO Outlines Strategic Vision for Fut - GuruFocus

Click here to get full coverage on CNS Pharmaceuticals, Inc. (NASDAQ:CNSP): When Will It Breakeven? - Yahoo Finance

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP): When Will It Breakeven?  Yahoo Finance

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP): When Will It Breakeven? - Yahoo Finance

Click here to get full coverage on Brain cancer drug developer hires CFO, CTO and CBO in strategic reset - Stock Titan

Brain cancer drug developer hires CFO, CTO and CBO in strategic reset  Stock Titan

Brain cancer drug developer hires CFO, CTO and CBO in strategic reset - Stock Titan

Click here to get full coverage on CNS Pharmaceuticals (CNSP) appoints new CFO and reassigns current finance chief - Stock Titan

CNS Pharmaceuticals (CNSP) appoints new CFO and reassigns current finance chief  Stock Titan

CNS Pharmaceuticals (CNSP) appoints new CFO and reassigns current finance chief - Stock Titan

Click here to get full coverage on Brain cancer drug developer taps new CEO with global track record - Stock Titan

Brain cancer drug developer taps new CEO with global track record  Stock Titan

Brain cancer drug developer taps new CEO with global track record - Stock Titan

Click here to get full coverage on CNS Pharmaceuticals (NASDAQ: CNSP) trims Q3 loss, cash funds operations into 2026 - Stock Titan

CNS Pharmaceuticals (NASDAQ: CNSP) trims Q3 loss, cash funds operations into 2026  Stock Titan

CNS Pharmaceuticals (NASDAQ: CNSP) trims Q3 loss, cash funds operations into 2026 - Stock Titan

Click here to get full coverage on New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug - Stock Titan

New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug  Stock Titan

New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug - Stock Titan

Click here to get full coverage on Brain Cancer Drug Developer CNS Pharmaceuticals Announces 1:12 Reverse Split to Maintain Nasdaq Listing - Stock Titan

Brain Cancer Drug Developer CNS Pharmaceuticals Announces 1:12 Reverse Split to Maintain Nasdaq Listing  Stock Titan

Brain Cancer Drug Developer CNS Pharmaceuticals Announces 1:12 Reverse Split to Maintain Nasdaq Listing - Stock Titan

Click here to get full coverage on Brain Cancer Breakthrough: CNS Pharma's TPI 287 Shows 52% Response Rate in Phase 1 GBM Trial - Stock Titan

Brain Cancer Breakthrough: CNS Pharma's TPI 287 Shows 52% Response Rate in Phase 1 GBM Trial  Stock Titan

Brain Cancer Breakthrough: CNS Pharma's TPI 287 Shows 52% Response Rate in Phase 1 GBM Trial - Stock Titan

Click here to get full coverage on NIGER: “THREATENED AND BROUGHT TO HEEL” - Amnesty International

NIGER: “THREATENED AND BROUGHT TO HEEL”  Amnesty International

NIGER: “THREATENED AND BROUGHT TO HEEL” - Amnesty International

Click here to get full coverage on CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22 - The Globe and Mail

CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22  The Globe and Mail

CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22 - The Globe and Mail

Click here to get full coverage on CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Yahoo Finance

CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules  Yahoo Finance

CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Yahoo Finance

Click here to get full coverage on CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved - Stocktwits

CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved  Stocktwits

CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved - Stocktwits

Click here to get full coverage on New Brain Cancer Drug Matches Standard Treatment with Better Safety Profile: Trial Results - Stock Titan

New Brain Cancer Drug Matches Standard Treatment with Better Safety Profile: Trial Results  Stock Titan

New Brain Cancer Drug Matches Standard Treatment with Better Safety Profile: Trial Results - Stock Titan

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on 41st Surface Line Week Kicks Off in San Diego - cpf.navy.mil

41st Surface Line Week Kicks Off in San Diego  cpf.navy.mil

41st Surface Line Week Kicks Off in San Diego - cpf.navy.mil

Click here to get full coverage on CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Stock Titan

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement  Stock Titan

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Stock Titan

Click here to get full coverage on Commander, Naval Surface Group, Middle Pacific Change of Command - cpf.navy.mil

Commander, Naval Surface Group, Middle Pacific Change of Command  cpf.navy.mil

Commander, Naval Surface Group, Middle Pacific Change of Command - cpf.navy.mil

Click here to get full coverage on CNS Pharmaceuticals (CNSP) - Zacks Investment Research

CNS Pharmaceuticals (CNSP)  Zacks Investment Research

CNS Pharmaceuticals (CNSP) - Zacks Investment Research

Click here to get full coverage on CNS Pharmaceuticals Announces Reverse Stock Split | CNSP Stock News - Stock Titan

CNS Pharmaceuticals Announces Reverse Stock Split | CNSP Stock News  Stock Titan

CNS Pharmaceuticals Announces Reverse Stock Split | CNSP Stock News - Stock Titan

Click here to get full coverage on CNS Pharmaceuticals Inc prevede una perdita di 9,66 dollari per azione - Anteprima degli utili - TradingView

CNS Pharmaceuticals Inc prevede una perdita di 9,66 dollari per azione - Anteprima degli utili  TradingView

CNS Pharmaceuticals Inc prevede una perdita di 9,66 dollari per azione - Anteprima degli utili - TradingView

Click here to get full coverage on CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin - PR Newswire

CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin  PR Newswire

CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin - PR Newswire

Click here to get full coverage on CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement - Stock Titan

CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement  Stock Titan

CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement - Stock Titan

Click here to get full coverage on CNS Pharma's Berubicin Shows Higher Patient Retention in Pivotal GBM Trial - Stock Titan

CNS Pharma's Berubicin Shows Higher Patient Retention in Pivotal GBM Trial  Stock Titan

CNS Pharma's Berubicin Shows Higher Patient Retention in Pivotal GBM Trial - Stock Titan

Click here to get full coverage on News - Boatswain's Mate Embraces Tradition, Legacy of Rating, to Transform CNSP Headquarters - DVIDS

News - Boatswain's Mate Embraces Tradition, Legacy of Rating, to Transform CNSP Headquarters  DVIDS

News - Boatswain's Mate Embraces Tradition, Legacy of Rating, to Transform CNSP Headquarters - DVIDS

Click here to get full coverage on CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | CNSP Stock News - Stock Titan

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | CNSP Stock News  Stock Titan

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules | CNSP Stock News - Stock Titan

Click here to get full coverage on CNSP/CNSL Host Staff Talks to Better Align Process and Help Commanders ‘Own The Fight’ - DVIDS

CNSP/CNSL Host Staff Talks to Better Align Process and Help Commanders ‘Own The Fight’  DVIDS

CNSP/CNSL Host Staff Talks to Better Align Process and Help Commanders ‘Own The Fight’ - DVIDS

Click here to get full coverage on Why has Niger declared US military presence in its territory illegal? - Peoples Dispatch

Why has Niger declared US military presence in its territory illegal?  Peoples Dispatch

Why has Niger declared US military presence in its territory illegal? - Peoples Dispatch

Click here to get full coverage on CNSP stock touches 52-week low at $0.08 amid sharp annual decline - Investing.com

CNSP stock touches 52-week low at $0.08 amid sharp annual decline  Investing.com

CNSP stock touches 52-week low at $0.08 amid sharp annual decline - Investing.com

Click here to get full coverage on Niger expels Chinese oil officials amid new tensions in the downstream - African Energy

Niger expels Chinese oil officials amid new tensions in the downstream  African Energy

Niger expels Chinese oil officials amid new tensions in the downstream - African Energy

Click here to get full coverage on Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today? - InvestorPlace

Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?  InvestorPlace

Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today? - InvestorPlace

Click here to get full coverage on Commander, Naval Surface Force, U.S. Pacific Fleet Names Sea, Shore and Reserve Sailors of the Year - DVIDS

Commander, Naval Surface Force, U.S. Pacific Fleet Names Sea, Shore and Reserve Sailors of the Year  DVIDS

Commander, Naval Surface Force, U.S. Pacific Fleet Names Sea, Shore and Reserve Sailors of the Year - DVIDS

Click here to get full coverage on Boatswain's Mate Embraces Tradition, Legacy of Rating, to Transform CNSP Headquarters [Image 1 of 3] - DVIDS

Boatswain's Mate Embraces Tradition, Legacy of Rating, to Transform CNSP Headquarters [Image 1 of 3]  DVIDS

Boatswain's Mate Embraces Tradition, Legacy of Rating, to Transform CNSP Headquarters [Image 1 of 3] - DVIDS

Click here to get full coverage on CNSP Stock Price and Chart — NASDAQ:CNSP - TradingView

CNSP Stock Price and Chart — NASDAQ:CNSP  TradingView

CNSP Stock Price and Chart — NASDAQ:CNSP - TradingView

Click here to get full coverage on US plans to resume partnership with Niger, diplomat says - Reuters

US plans to resume partnership with Niger, diplomat says  Reuters

US plans to resume partnership with Niger, diplomat says - Reuters

Click here to get full coverage on Core Tenets of a Cloud Native Security Platform (CNSP) - Palo Alto Networks

Core Tenets of a Cloud Native Security Platform (CNSP)  Palo Alto Networks

Core Tenets of a Cloud Native Security Platform (CNSP) - Palo Alto Networks

Click here to get full coverage on ECOWAS must look beyond the use of force in Niger - ISS Africa

ECOWAS must look beyond the use of force in Niger  ISS Africa

ECOWAS must look beyond the use of force in Niger - ISS Africa

Click here to get full coverage on News - Commander, Naval Surface Forces Holds Change of Command - DVIDS

News - Commander, Naval Surface Forces Holds Change of Command  DVIDS

News - Commander, Naval Surface Forces Holds Change of Command - DVIDS

Click here to get full coverage on Mali, a Coup within a Coup - International Crisis Group

Mali, a Coup within a Coup  International Crisis Group

Mali, a Coup within a Coup - International Crisis Group

Click here to get full coverage on CNS Pharmaceuticals faces NASDAQ delisting over price rule - Investing.com

CNS Pharmaceuticals faces NASDAQ delisting over price rule  Investing.com

CNS Pharmaceuticals faces NASDAQ delisting over price rule - Investing.com

Click here to get full coverage on CNSP Resolution No. 471/2024: guidelines on own risk and solvency assessment and capital management defined - Demarest

CNSP Resolution No. 471/2024: guidelines on own risk and solvency assessment and capital management defined  Demarest

CNSP Resolution No. 471/2024: guidelines on own risk and solvency assessment and capital management defined - Demarest

Click here to get full coverage on News - CNSP Celebrates 126th Chief Petty Officer Birthday - DVIDS

News - CNSP Celebrates 126th Chief Petty Officer Birthday  DVIDS

News - CNSP Celebrates 126th Chief Petty Officer Birthday - DVIDS

Click here to get full coverage on News - CNSP Encourages Bunker Hill Sailors to Commit to a Culture of Excellence - DVIDS

News - CNSP Encourages Bunker Hill Sailors to Commit to a Culture of Excellence  DVIDS

News - CNSP Encourages Bunker Hill Sailors to Commit to a Culture of Excellence - DVIDS

Click here to get full coverage on News - SURFOR Hosts Third Annual Junior Officer Training Symposium - DVIDS

News - SURFOR Hosts Third Annual Junior Officer Training Symposium  DVIDS

News - SURFOR Hosts Third Annual Junior Officer Training Symposium - DVIDS

Click here to get full coverage on Mali Coup d’État: The soldiers who brought down IBK - The Africa Report

Mali Coup d’État: The soldiers who brought down IBK  The Africa Report

Mali Coup d’État: The soldiers who brought down IBK - The Africa Report

Click here to get full coverage on Commander, Naval Surfaces Force, U.S. Pacific Fleet names Surface Warfare Officer of the Year - DVIDS

Commander, Naval Surfaces Force, U.S. Pacific Fleet names Surface Warfare Officer of the Year  DVIDS

Commander, Naval Surfaces Force, U.S. Pacific Fleet names Surface Warfare Officer of the Year - DVIDS

Click here to get full coverage on News - Embedded Mental Health Building Now Available on the Waterfront in San Diego - DVIDS

News - Embedded Mental Health Building Now Available on the Waterfront in San Diego  DVIDS

News - Embedded Mental Health Building Now Available on the Waterfront in San Diego - DVIDS

Click here to get full coverage on CNSP defines guidelines for obtaining sustainability seal - Demarest

CNSP defines guidelines for obtaining sustainability seal  Demarest

CNSP defines guidelines for obtaining sustainability seal - Demarest

Click here to get full coverage on News - FORCM James Osborne retires from the Navy after 34 Years of Service - DVIDS

News - FORCM James Osborne retires from the Navy after 34 Years of Service  DVIDS

News - FORCM James Osborne retires from the Navy after 34 Years of Service - DVIDS

Click here to get full coverage on US, Niger extend official high-level talks on US troop withdrawal into Friday - VOA - Voice of America English News

US, Niger extend official high-level talks on US troop withdrawal into Friday  VOA - Voice of America English News

US, Niger extend official high-level talks on US troop withdrawal into Friday - VOA - Voice of America English News

Click here to get full coverage on CNSP Resolution No. 478/2024: general guidelines on Vehicle Liability Insurance (RC-V) in road cargo transportation defined - Demarest

CNSP Resolution No. 478/2024: general guidelines on Vehicle Liability Insurance (RC-V) in road cargo transportation defined  Demarest

CNSP Resolution No. 478/2024: general guidelines on Vehicle Liability Insurance (RC-V) in road cargo transportation defined - Demarest

Click here to get full coverage on Here's Why CNS Pharmaceuticals (NASDAQ:CNSP) Must Use Its Cash Wisely - Nasdaq

Here's Why CNS Pharmaceuticals (NASDAQ:CNSP) Must Use Its Cash Wisely  Nasdaq

Here's Why CNS Pharmaceuticals (NASDAQ:CNSP) Must Use Its Cash Wisely - Nasdaq

Click here to get full coverage on Niger's junta revokes military agreement with US - BBC

Niger's junta revokes military agreement with US  BBC

Niger's junta revokes military agreement with US - BBC

Click here to get full coverage on Niger Orders American Troops to Leave Its Territory (Published 2024) - The New York Times

Niger Orders American Troops to Leave Its Territory (Published 2024)  The New York Times

Niger Orders American Troops to Leave Its Territory (Published 2024) - The New York Times

Click here to get full coverage on CNSP stock touches 52-week low at $0.09 amid sharp decline - Investing.com

CNSP stock touches 52-week low at $0.09 amid sharp decline  Investing.com

CNSP stock touches 52-week low at $0.09 amid sharp decline - Investing.com

Click here to get full coverage on Mali: President Bah N’Daw decrees the dissolution of the CNSP - The Africa Report

Mali: President Bah N’Daw decrees the dissolution of the CNSP  The Africa Report

Mali: President Bah N’Daw decrees the dissolution of the CNSP - The Africa Report

Click here to get full coverage on CNS Pharmaceuticals Announces Reverse Stock Split - Yahoo Finance

CNS Pharmaceuticals Announces Reverse Stock Split  Yahoo Finance

CNS Pharmaceuticals Announces Reverse Stock Split - Yahoo Finance

Click here to get full coverage on The International Community’s Soft Acceptance of the Coup in Mali - IPI Global Observatory

The International Community’s Soft Acceptance of the Coup in Mali  IPI Global Observatory

The International Community’s Soft Acceptance of the Coup in Mali - IPI Global Observatory

Click here to get full coverage on Mali Coup Leaders Pledge Democracy After Deposing President (Published 2020) - The New York Times

Mali Coup Leaders Pledge Democracy After Deposing President (Published 2020)  The New York Times

Mali Coup Leaders Pledge Democracy After Deposing President (Published 2020) - The New York Times

Click here to get full coverage on Holtec / US Company Unveils Power Plant Design Combining Nuclear and Solar Energy - NucNet

Holtec / US Company Unveils Power Plant Design Combining Nuclear and Solar Energy  NucNet

CNSP

Price Chart

Key Statistics

Technicals

About CNSP

Latest News

Brain cancer drug developer hires veteran surgeon to lead studies - Stock Titan

Understanding Momentum Shifts in (CNSP) - Stock Traders Daily

CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer - The Globe and Mail

Advanced Charts

Top Gainers

Top Losers